Clinical Trials Browser

Recurrence, Neoplasms, Plasma Cell

NCT06986434 2026-04-08

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation

Phase EARLY_PHASE1 Not yet recruiting

20 enrolled

LymphoidPlasma cell

Lymphoma, Recurrence, Neoplasms, Plasma Cell

NCT06142396 2026-03-12

Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure

Phase EARLY_PHASE1 Recruiting

30 enrolled

Plasma cell

Multiple Myeloma, Renal Insufficiency

NCT05495464 2026-02-27

A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma

Phase EARLY_PHASE1 Active not recruiting

22 enrolled

Lymphoid

Lymphoma, Lymphoma, Mantle-Cell

NCT06942039 2026-02-27

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

Phase EARLY_PHASE1 Recruiting

15 enrolled

CNS

Medulloblastoma, Neuroblastoma, Pinealoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor, Pyloric Stenosis, Hypertrophic

NCT07416682 2026-02-25

CAR BCMA-70 CAR-T Cells for the Treatment of High-risk Plasma Cell Neoplasms

Phase EARLY_PHASE1 Not yet recruiting

20 enrolled

Plasma cell

High-risk Plasma Cell Neoplasms

NCT07242417 2026-01-21

TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

30 enrolled

Gastrointestinal

Solid Cancer

NCT07342738 2026-01-15

TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors

Phase EARLY_PHASE1 Not yet recruiting

25 enrolled

Other solid neoplasm

KRAS G12V

NCT07246304 2025-11-24

TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC

Phase EARLY_PHASE1 Recruiting

24 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT01760226 2025-10-14

DA-EPOCH-R

Phase EARLY_PHASE1 Completed

4 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT02652455 2025-08-19

Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma

Phase EARLY_PHASE1 Completed

11 enrolled

Dermatologic

Melanoma, Skin Neoplasms

NCT03719105 2025-08-08

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

Phase EARLY_PHASE1 Recruiting

40 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, T-Cell, Peripheral, Leukemia, Large Granular Lymphocytic

NCT04947501 2025-08-05

A Study of N9 Chemotherapy in Children With Neuroblastoma

Phase EARLY_PHASE1 Active not recruiting

26 enrolled

CNS

Neoplasms, Neuroblastoma

NCT04139304 2025-06-29

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Phase EARLY_PHASE1 Recruiting

15 enrolled

Lymphoid

Plasmablastic Lymphoma

NCT06092047 2025-05-16

UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies.

Phase EARLY_PHASE1 Recruiting

10 enrolled

Lymphoid

CD19-positive Relapsed or Refractory B-cell Malignancies

NCT01184885 2025-05-04

A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy

Phase EARLY_PHASE1 Completed

7 enrolled 8 charts

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Recurrence, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

CAR 70-BCMA CAR-T Cells for the Treatment of Relapsed or Refractory Plasma Cell Neoplasms

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation

Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure

A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

CAR BCMA-70 CAR-T Cells for the Treatment of High-risk Plasma Cell Neoplasms

TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors

TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors

TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC

DA-EPOCH-R

Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

A Study of N9 Chemotherapy in Children With Neuroblastoma

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies.

A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy